Are you ready to optimize your preconception nutrition
Postmenopausal osteoporosis (type I): After menopause, women experience a sudden drop in estrogen levels, a significant increase in osteoclast activity, accelerated bone resorption, insufficient osteoblast activity, and rapid loss of bone mass (30% -50% loss after 5-10 years of menopause), mainly in the lumbar spine and hip
Our products are supplied strictly for laboratory research purposes and are handled according to strict quality and sterility standards
Researchers across major Australian research hubs including Sydney, Melbourne, Brisbane, Perth and Adelaide increasingly source high-purity peptide compounds for experimental investigation
More notably, citalopram treatment significantly increased the number of TdT-mediated dUTP nick end labeling (TUNEL)-positive cells, whereas melatonin and vitamin C treatment significantly attenuated citalopram-induced apoptosis
These results support PD as a natural co-therapeutic agent with MTX in 3D HepG2 spheroid models